Showing results (651-660 of 1,395) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|June 7, 2023
Distinguishing Renal Cell Carcinoma From Normal Kidney Tissue Using Mass Spectrometry Imaging Combined With Machine LearningVishnu Shankar, Kanchustambham Vijayalakshmi, Rosalie Nolley, et al.
JCO Precision Oncology|March 2, 2026
Developing a Metabolic-Associated Prognostic Index for Risk Stratification and Therapeutic Guidance in Stage I Lung Adenocarcinoma via Multiomics AnalysisPengcheng Liu, Zhongxu Chen, Hui Hong, et al.
JCO Precision Oncology|February 20, 2026
Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1ENeal Akhave, Zihe Song, David S Hong, et al.
JCO Precision Oncology|March 2, 2026
Machine Learning-Driven Risk Stratification and Adjuvant Treatment Guidance in Oral Cavity CancerAndrea Costantino, Nir Tsur, Daniel Uralov, et al.
JCO Precision Oncology|February 19, 2026
Prognostic Implications of Codon-Specific KRAS Mutations in Localized and Advanced Stages of Pancreatic CancerSara Raji, Hamed Zaribafzadeh, Tyler Jones, et al.
JCO Precision Oncology|November 22, 2024
Safety and Efficacy of Osimertinib in Patients With Non-Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-AnalysisJonathan N Priantti, Yu Fujiwara, Francisco Cezar Aquino de Moraes, et al.
JCO Precision Oncology|October 21, 2024
Microsatellite Instability and Clinical Use in Sarcomas: Systematic Review and Illustrative Case ReportItalo Fernandes, Douglas Dias E Silva, Vanderlei Segatelli, et al.
JCO Precision Oncology|October 21, 2024
Toxicity Adaptive Lists Design: A Practical Design for Phase I Drug Combination Trials in OncologyMassimiliano Russo, Francesco Mariani, James M Cleary, et al.
JCO Precision Oncology|October 24, 2024
Comprehensive Genomic Assessment of Advanced-Stage GI Stromal Tumors Using the Japanese National Center for Cancer Genomics and Advanced Therapeutics DatabaseHiroyuki Fujii, Hidekazu Hirano, Kouya Shiraishi, et al.
JCO Precision Oncology|October 24, 2024
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital HistopathologyJonathan David Tward, Huei-Chung Huang, Andre Esteva, et al.
Pageof 140